ICU Medical vs Neogen
ICU Medical reported revenue of $2.2 billion in fiscal 2025, 2.6 times Neogen's $870 million in fiscal 2026. ICU Medical's revenue fell 6.3% in its latest year, and Neogen's fell 2.7%. ICU Medical had an operating margin of 1.9%, against -2.5% at Neogen. Free cash flow was $92 million at ICU Medical and $32 million at Neogen. Their fiscal years end in different months (December 31 and May 31), so the periods don't line up exactly.
Side by side
| ICU Medical | Neogen | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2026, May 31, 2026 |
| Revenue | $2.2B | $870M |
| Revenue growth | −6.3% | −2.7% |
| Revenue growth a year, last 5 years | 11.9% | 13.2% |
| Gross margin | 36.8% | 46.9% |
| Operating margin | 1.9% | −2.5% |
| Net margin | 0.0% | −0.9% |
| Free cash flow | $92M | $32M |
| Free cash flow margin | 4.1% | 3.7% |
| Return on capital | 0.7% | −0.6% |
| Net debt to EBITDA | 4.0x | 6.4x |
| Dividends and buybacks | $9M | $0M |
| Change in diluted share count | 2.1% | 0.3% |
| Last close | $172.11 | $11.76 |
| P/E at the last close | 71.7× | — |
| Insider trades, last 12 months | sold $8.3 million | bought $6,386, sold $114,676 |
| Piotroski F-score | 6 of 9 | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
ICU MedicalNeogen
Operating margin
Percent of revenue
ICU MedicalNeogen
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ICU MedicalNeogen
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the ICU Medical and Neogen pages.